Sponsor study identifier
observational
60
1 country
1
Study Start
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Program: Clinical Study of Relationship Between Granulocyte Activation, HDAC2 and Severe Asthma Aim:The early prediction of severe asthma, early intervention on the disease, reduce the family and the national finance. design:This study is a single center randomized controlled trial designed by the Department of respiratory medicine, Xijing Hospital, as the main research unit.Compare the case group(severe asthma group and mild-and-moderate asthma group) and control group(healthy control group) by detecting the activity of MPO、NE、MMP-9 and ECP in the peripheral blood and the activity of HDAC2 in PBMCs of patients. case:60 Case selection: Inclusion criteria: age 18-75 years old; diagnosis of asthma was clear; informed consent was signed. Exclusion criteria: poor compliance; cognitive ability is low; psychiatric disorders need to be combined with psychotropic medication.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
July 15, 2016
Actual (reported)August 29, 2016
Actual (reported)July 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Evidence of clinically definite severe asthma confirmed by the plasma concentration of blood related indexes(MPO、MMP-9、NE、ECP、HDAC2)
Compare the difference was not statistically significant of the different groups by testing the concentration of blood related indicators of subjects
one year
Mainly from students, family members of patients without chronic lung disease, healthy population, age 18-75 years old, the gender is not limited.
Patients diagnosed with asthma in the outpatient clinic, in accordance with the inclusion criteria and exclusion criteria.
Outpatient patients with severe asthma diagnosis, in accordance with the inclusion criteria and exclusion criteria.
No intervention
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
outpatients and the students
XijingH
Xian, Shanxi, 780032, China
blood
Wu C gui, professor
Xijing Hospital
First Submitted
July 15, 2016
First Posted
August 29, 2016
Study Start
June 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2017
Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 29, 2016
Record last verified: 2016-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: